Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Clinical Trials Related to Merck Sharp & Dohme LLC
Related studies linked through entity extraction aliases.
Pembrolizumab and BCG Solution in Treating Patients With Recurrent Non-Muscle-Invasive Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects
- Status
- COMPLETED
- Phase
- PHASE2
Deep vs Moderate Block: Impact on Operating Conditions & Patient Satisfaction
- Status
- WITHDRAWN
- Phase
- PHASE4
Imaging FDG Flare in Melanoma
- Status
- COMPLETED
- Phase
- N/A
A Study of the Safety and Efficacy of Sitagliptin Addition During Metformin Up-titration (MK-0431-848)
- Status
- COMPLETED
- Phase
- PHASE3
Trial of Alvimopan in Major Spine Surgery
- Status
- COMPLETED
- Phase
- PHASE4
Study of Pembrolizumab (MK-3475) in Participants With Metastatic Castration-Resistant Prostate Cancer (mCRPC)(MK-3475-199/KEYNOTE-199)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Oral Treatments for Hepatitis C
- Status
- COMPLETED
- Phase
- PHASE4
Pembrolizumab in Patients With Advanced Malignant Pleural Mesothelioma
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
- Status
- COMPLETED
- Phase
- PHASE4
A Study of Abemaciclib (LY2835219) in Participants With Non-Small Cell Lung Cancer or Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab in Combination With Cisplatin and Intensity Modulated Radiotherapy (IMRT) in Head and Neck Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Carboplatin-Paclitaxel/Nab-Paclitaxel Chemotherapy With or Without Pembrolizumab (MK-3475) in Adults With First Line Metastatic Squamous Non-small Cell Lung Cancer (MK-3475-407/KEYNOTE-407)
- Status
- COMPLETED
- Phase
- PHASE3
Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and Neck
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
High Dose Cytarabine Followed by Pembrolizumab in Relapsed/Refractory AML
- Status
- COMPLETED
- Phase
- PHASE2
Study Of Single-dose Cyclophosphamide +Pembrolizumab In Patients With Metastatic Triple Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Phase II: Pembrolizumab/Carboplatin/Taxol in Epithelial Ovary Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Chemoradiation Plus Pembrolizumab for Locally Advanced Laryngeal Squamous Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2